AAPL   396.35 (+3.30%)
MSFT   215.10 (+0.67%)
FB   247.97 (+1.18%)
GOOGL   1,566.34 (+1.78%)
NVDA   423.74 (+1.09%)
CGC   17.96 (+3.10%)
BABA   258.41 (-1.00%)
MU   50.95 (+0.49%)
GE   6.76 (+0.90%)
TSLA   1,703.73 (+10.30%)
T   29.88 (-0.83%)
ACB   12.47 (+3.74%)
F   6.20 (+1.64%)
GILD   77.80 (+1.94%)
DIS   119.91 (+0.48%)
BAC   24.20 (+0.75%)
BA   181.90 (+1.94%)
AAPL   396.35 (+3.30%)
MSFT   215.10 (+0.67%)
FB   247.97 (+1.18%)
GOOGL   1,566.34 (+1.78%)
NVDA   423.74 (+1.09%)
CGC   17.96 (+3.10%)
BABA   258.41 (-1.00%)
MU   50.95 (+0.49%)
GE   6.76 (+0.90%)
TSLA   1,703.73 (+10.30%)
T   29.88 (-0.83%)
ACB   12.47 (+3.74%)
F   6.20 (+1.64%)
GILD   77.80 (+1.94%)
DIS   119.91 (+0.48%)
BAC   24.20 (+0.75%)
BA   181.90 (+1.94%)
AAPL   396.35 (+3.30%)
MSFT   215.10 (+0.67%)
FB   247.97 (+1.18%)
GOOGL   1,566.34 (+1.78%)
NVDA   423.74 (+1.09%)
CGC   17.96 (+3.10%)
BABA   258.41 (-1.00%)
MU   50.95 (+0.49%)
GE   6.76 (+0.90%)
TSLA   1,703.73 (+10.30%)
T   29.88 (-0.83%)
ACB   12.47 (+3.74%)
F   6.20 (+1.64%)
GILD   77.80 (+1.94%)
DIS   119.91 (+0.48%)
BAC   24.20 (+0.75%)
BA   181.90 (+1.94%)
AAPL   396.35 (+3.30%)
MSFT   215.10 (+0.67%)
FB   247.97 (+1.18%)
GOOGL   1,566.34 (+1.78%)
NVDA   423.74 (+1.09%)
CGC   17.96 (+3.10%)
BABA   258.41 (-1.00%)
MU   50.95 (+0.49%)
GE   6.76 (+0.90%)
TSLA   1,703.73 (+10.30%)
T   29.88 (-0.83%)
ACB   12.47 (+3.74%)
F   6.20 (+1.64%)
GILD   77.80 (+1.94%)
DIS   119.91 (+0.48%)
BAC   24.20 (+0.75%)
BA   181.90 (+1.94%)
Log in

NASDAQ:BABYNatus Medical Social Media Mentions

Notice: This company has been marked as potentially delisted and may not be actively trading.
$21.15
+0.40 (+1.93 %)
(As of 07/13/2020 01:16 PM ET)
Add
Compare
Today's Range
$20.53
Now: $21.15
$21.29
50-Day Range
$26.75
MA: $29.96
$31.92
52-Week Range
$23.53
Now: $21.15
$37.90
Volume132,200 shs
Average Volume165,325 shs
Market Capitalization$719.31 million
P/E Ratio14.89
Dividend YieldN/A
Beta0.57

Social Media

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.